Business Context and Reporting Period
This Form 8-K is filed by Health Sciences Acquisitions Corporation 2 (the "Company"), a Cayman Islands emerging growth company, on February 4, 2022. The filing addresses a material reclassification of equity and a change in earnings per share presentation affecting financial statements issued between August 2020 and September 2021.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. It explicitly states that the reclassification of ordinary shares from permanent equity to temporary equity has no impact on the Company's cash position or cash held in the trust account established in connection with the IPO.
Material Changes Versus Prior Period
- Equity Reclassification: The Company reclassified all ordinary shares from permanent equity to temporary equity following a re-evaluation of ASC 480-10-S99. Previously, a portion was classified as permanent equity to maintain net tangible assets above $5,000,000.
- Earnings Per Share: The presentation of earnings per share has been revised in connection with the equity reclassification.
- Materiality Determination: While initially deemed not qualitatively material, the Company determined the changes are quantitatively material, necessitating a restatement of previously issued financial statements.
Guidance, Outlook, Risks, and Contingencies
- Restatement Plan: The Company plans to file amendments to its Form 10-K for the period ended December 31, 2020; its Form 10-Q for the period ended September 30, 2021; and its Form 8-K regarding the Post-IPO Balance Sheet.
- Internal Control Weakness: Management concluded that a material weakness exists in internal control over financial reporting and that disclosure controls and procedures were not effective due to the classification error.
- Auditor Notification: The matter has been discussed with WithumSmith+Brown, PC, the Company's independent registered public accounting firm.
- Non-Reliance Notice: Investors are advised not to rely on the "Affected Filings" listed in Item 4.02, which include reports filed from August 2020 through November 2021.
Important Facts for Investor Verification
- Verify the upcoming amended filings (10-K, 10-Q, and 8-K) to obtain the restated financial statements.
- Confirm the impact of the temporary equity classification on the Company's ability to meet the $5,000,001 net tangible asset requirement for consummating an initial business combination.
- Review the Company's remediation plan for the identified material weakness in internal controls over financial reporting.
- Note that the filing explicitly states no impact on cash or trust account balances.